JP2024502954A5 - - Google Patents
Info
- Publication number
- JP2024502954A5 JP2024502954A5 JP2023539784A JP2023539784A JP2024502954A5 JP 2024502954 A5 JP2024502954 A5 JP 2024502954A5 JP 2023539784 A JP2023539784 A JP 2023539784A JP 2023539784 A JP2023539784 A JP 2023539784A JP 2024502954 A5 JP2024502954 A5 JP 2024502954A5
- Authority
- JP
- Japan
- Prior art keywords
- compound
- optionally substituted
- cells
- independently
- branched
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163139734P | 2021-01-20 | 2021-01-20 | |
| US63/139,734 | 2021-01-20 | ||
| PCT/US2022/012941 WO2022159463A1 (en) | 2021-01-20 | 2022-01-19 | Nanomaterials |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024502954A JP2024502954A (ja) | 2024-01-24 |
| JP2024502954A5 true JP2024502954A5 (cg-RX-API-DMAC10.html) | 2025-01-24 |
Family
ID=82549752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023539784A Pending JP2024502954A (ja) | 2021-01-20 | 2022-01-19 | ナノ材料 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12059477B2 (cg-RX-API-DMAC10.html) |
| EP (1) | EP4281050A4 (cg-RX-API-DMAC10.html) |
| JP (1) | JP2024502954A (cg-RX-API-DMAC10.html) |
| KR (1) | KR20230131863A (cg-RX-API-DMAC10.html) |
| CN (1) | CN116761888A (cg-RX-API-DMAC10.html) |
| AU (1) | AU2022210313A1 (cg-RX-API-DMAC10.html) |
| CA (1) | CA3203742A1 (cg-RX-API-DMAC10.html) |
| IL (1) | IL303846A (cg-RX-API-DMAC10.html) |
| MX (1) | MX2023008333A (cg-RX-API-DMAC10.html) |
| WO (1) | WO2022159463A1 (cg-RX-API-DMAC10.html) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7600208B2 (ja) | 2019-07-29 | 2024-12-16 | ジョージア テック リサーチ コーポレイション | 拘束された脂質を含むナノ材料およびその使用 |
| CN115175894B (zh) | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| CA3203741A1 (en) * | 2021-01-20 | 2022-07-28 | Beam Therapeutics Inc. | Nanomaterials comprising an ionizable lipid |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| EP4540222A1 (en) | 2022-07-20 | 2025-04-23 | Beam Therapeutics Inc. | Nanomaterials comprising triols |
| EP4719352A1 (en) | 2023-05-31 | 2026-04-08 | Capstan Therapeutics, Inc. | Lipid nanoparticle formulations and compositions |
Family Cites Families (38)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5110977A (en) | 1990-02-14 | 1992-05-05 | Eastman Kodak Company | Ester-containing quaternary ammonium salts as adhesion improving toner charge agents |
| EP1021549A2 (en) | 1997-09-19 | 2000-07-26 | Sequitur, Inc. | SENSE mRNA THERAPY |
| EP2279254B1 (en) | 2008-04-15 | 2017-07-05 | Protiva Biotherapeutics Inc. | Novel lipid formulations for nucleic acid delivery |
| US9512073B2 (en) | 2011-10-27 | 2016-12-06 | Massachusetts Institute Of Technology | Amino acid-, peptide-and polypeptide-lipids, isomers, compositions, and uses thereof |
| ES2887254T3 (es) | 2013-03-08 | 2021-12-22 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
| US20150166984A1 (en) | 2013-12-12 | 2015-06-18 | President And Fellows Of Harvard College | Methods for correcting alpha-antitrypsin point mutations |
| US10426737B2 (en) | 2013-12-19 | 2019-10-01 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| US10059655B2 (en) | 2013-12-19 | 2018-08-28 | Novartis Ag | Lipids and lipid compositions for the delivery of active agents |
| ES2969956T3 (es) | 2014-09-05 | 2024-05-23 | Novartis Ag | Lípidos y composiciones lipídicas para el suministro de agentes activos |
| WO2016187531A1 (en) | 2015-05-21 | 2016-11-24 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derivatives and uses thereof |
| HRP20220156T1 (hr) | 2015-09-17 | 2022-04-15 | Modernatx, Inc. | Spojevi i pripravci za unutarstaničnu isporuku terapeutskih sredstava |
| WO2017070632A2 (en) | 2015-10-23 | 2017-04-27 | President And Fellows Of Harvard College | Nucleobase editors and uses thereof |
| WO2018027078A1 (en) | 2016-08-03 | 2018-02-08 | President And Fellows Of Harard College | Adenosine nucleobase editors and uses thereof |
| KR102710962B1 (ko) | 2017-07-04 | 2024-09-27 | 주식회사 인투셀 | 절단성 링커를 포함하는 화합물 및 이들의 용도 |
| JP7449231B2 (ja) | 2017-10-30 | 2024-03-13 | ジョージア テック リサーチ コーポレーション | 組織送達用材料の多重化解析 |
| US11622942B2 (en) | 2017-11-14 | 2023-04-11 | Ohio State Innovation Foundation | Benzene-1,3,5-tricarboxamide derived ester lipids and uses thereof |
| MX2021003455A (es) | 2018-10-02 | 2021-09-21 | Intellia Therapeutics Inc | Lípidos con amina ionizables. |
| CN119285480A (zh) | 2018-12-05 | 2025-01-10 | 英特利亚治疗股份有限公司 | 改性的胺脂质 |
| EP3911302B1 (en) | 2019-01-17 | 2025-09-10 | Georgia Tech Research Corporation | Drug delivery systems containing oxidized cholesterols |
| EP3924479A4 (en) | 2019-02-13 | 2023-01-25 | Beam Therapeutics, Inc. | ADENOSINE DEAMINASE BASE EDITORS AND METHODS OF USING THEM TO MODIFY A NUCLEOBASE IN A TARGET SEQUENCE |
| WO2020219876A1 (en) | 2019-04-25 | 2020-10-29 | Intellia Therapeutics, Inc. | Ionizable amine lipids and lipid nanoparticles |
| US20220233459A1 (en) | 2019-06-05 | 2022-07-28 | Guide Therapeutics, Inc. | Analysis of materials for tissue delivery |
| EP4004207A4 (en) | 2019-07-29 | 2023-08-23 | Georgia Tech Research Corporation | OLIGONUCLEOTIDE ANTAGONISTS FOR RNA-GUIDED GENO EDITING |
| JP7600208B2 (ja) | 2019-07-29 | 2024-12-16 | ジョージア テック リサーチ コーポレイション | 拘束された脂質を含むナノ材料およびその使用 |
| JP7699128B2 (ja) | 2019-12-06 | 2025-06-26 | ガイド セラピューティクス,エルエルシー | ナノマテリアル |
| CN115175894B (zh) | 2020-01-09 | 2024-09-06 | 盖德治疗有限责任公司 | 纳米材料 |
| EP4262817A4 (en) | 2020-12-21 | 2025-03-12 | Beam Therapeutics Inc. | NANOMATERIALS WITH ACETALS |
| JP2024508347A (ja) | 2020-12-21 | 2024-02-27 | ビーム セラピューティクス インク. | エステル結合アセタールを含むナノ材料 |
| JP2024505327A (ja) | 2020-12-21 | 2024-02-06 | ビーム セラピューティクス インク. | 炭酸塩を含むナノ材料 |
| AU2022210299A1 (en) | 2021-01-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable lipids for nanomaterials |
| EP4281080A4 (en) | 2021-01-20 | 2025-09-24 | Beam Therapeutics Inc | NANOMATERIALS COMPRISING A BIODEGRADABLE ELEMENT |
| CN116761888A (zh) | 2021-01-20 | 2023-09-15 | 比姆医疗股份有限公司 | 纳米材料 |
| CA3203741A1 (en) | 2021-01-20 | 2022-07-28 | Beam Therapeutics Inc. | Nanomaterials comprising an ionizable lipid |
| CA3241488A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine lipids and lipid nanoparticles |
| WO2023121971A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising tetravalent lipid compounds |
| WO2023121970A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Ionizable amine and ester lipids and lipid nanoparticles |
| WO2023121964A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterials comprising disulfides |
| WO2023121965A1 (en) | 2021-12-20 | 2023-06-29 | Beam Therapeutics Inc. | Nanomaterial comprising diamines |
-
2022
- 2022-01-19 CN CN202280009717.5A patent/CN116761888A/zh active Pending
- 2022-01-19 EP EP22743085.7A patent/EP4281050A4/en active Pending
- 2022-01-19 US US17/579,115 patent/US12059477B2/en active Active
- 2022-01-19 JP JP2023539784A patent/JP2024502954A/ja active Pending
- 2022-01-19 WO PCT/US2022/012941 patent/WO2022159463A1/en not_active Ceased
- 2022-01-19 IL IL303846A patent/IL303846A/en unknown
- 2022-01-19 MX MX2023008333A patent/MX2023008333A/es unknown
- 2022-01-19 CA CA3203742A patent/CA3203742A1/en active Pending
- 2022-01-19 KR KR1020237024632A patent/KR20230131863A/ko active Pending
- 2022-01-19 AU AU2022210313A patent/AU2022210313A1/en active Pending
-
2024
- 2024-06-24 US US18/751,931 patent/US20250041441A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024505449A5 (cg-RX-API-DMAC10.html) | ||
| JP2024502948A5 (cg-RX-API-DMAC10.html) | ||
| JP2024503441A5 (cg-RX-API-DMAC10.html) | ||
| JP2025501731A5 (cg-RX-API-DMAC10.html) | ||
| JP2025500824A5 (cg-RX-API-DMAC10.html) | ||
| JP5813778B2 (ja) | トール様受容体に基づく免疫反応を調節するための免疫調節オリゴヌクレオチド(iro)化合物 | |
| EP2996472B1 (en) | Compositions and methods for inhibiting "stimulator of interferon gene" dependent signalling | |
| JP2024505327A (ja) | 炭酸塩を含むナノ材料 | |
| CN112805294A (zh) | 用于核酸递送的叔氨基脂化的阳离子肽 | |
| JP2018537528A (ja) | Nlrp3遺伝子発現を阻害するための組成物およびその使用 | |
| JP2019504002A5 (cg-RX-API-DMAC10.html) | ||
| AU2009302468A1 (en) | Use of inhibitors of toll-like receptors in the prevention and treatment of hypercholesterolemia and hyperlipidemia and diseases related thereto | |
| JP2024535004A (ja) | イオン化可能な脂質その調製および遺伝子送達における使用 | |
| CN117440834A (zh) | 核糖核酸的体内递送用组合物及其制备方法 | |
| CN116963729A (zh) | 包括可电离脂质的纳米材料 | |
| CN118421594A (zh) | 包含突变kras序列和脂质的化合物及其用途 | |
| CN116615472A (zh) | 聚合物缀合的脂质化合物和脂质纳米颗粒组合物 | |
| JP2024503976A5 (cg-RX-API-DMAC10.html) | ||
| BR112015016420B1 (pt) | Composto de oligonucleotídeo imunorregulatório, composição farmacêutica e uso do composto iro ou da composição farmacêutica | |
| JP2018150239A (ja) | β2GPI遺伝子発現抑制RNAi医薬組成物 | |
| WO2024183821A1 (zh) | 可离子化脂质分子及其制备方法和应用 | |
| TWI876778B (zh) | 用於傳遞核酸的基於環烷的脂質化合物以及包括其之脂質奈米粒子 | |
| WO2018084168A1 (ja) | 皮膚線維症処置剤 | |
| Gao et al. | Engineering a spleen-selective mRNA-LNPs vaccine by decoupling the inflammation from cellular immunity-mediated cancer immunotherapy | |
| US11802139B2 (en) | Pharmaceutical composition and the use thereof in the treatment of autoimmune diseases |